Will develop a dynamic model of response to HER family inhibitors in tumors in which HER2 is amplified that encompasses both fast, phosphorylation-based events (on the order of a few minutes) and slower transcriptional and epigenomic processes (on the order of a few days). This model will eventually enable comparative assessment ofthe relative importance of mechanisms of response and resistance and guide development of combinatorial therapeutic strategies to counter resistance. This project is motivated by observations that responses to trastuzumab and lapatinib are not uniform between patients and are frequently not durable. Work in this CCSB project and the general scientific community suggests several mechanisms that may confer resistance including: (a) activating downstream mutations in the PI3K pathway, (b) microenvironment mediated activation of interacting networks, (c) PI3K mediated changes in HERS expression and signaling and (d) transcriptional feedback regulation from response related network elements. An initial dynamic version ofthe model will be developed in collaboration with the MIT CCSB (see letter of collaboration from Dr. Lauffenburger). The model will differ from existing work in three important ways: it will exploit a mathematical separation of time scales for fast and slow dynamics, incorporate underlying genetic aberrations, and include parallel signaling from the microenvironment. Analysis ofthis initial model will be used to help understand the roles of cooperating genetic aberrations, transcriptional and translational regulation, vesicle control and microenvironment in fast and slow dynamic processes. Subsequent versions of the model will build on experimental measurements of temporal biological and molecular responses of HER2+ breast cancer cell lines to HER2 family signaling network inhibitors administered alone and in combination as well as information from Projects 1, 2 and 4 and from the Stanford CCSB's MYC modeling efforts (see letter of collaboration from Dr. Plevritis). A combination of Bayesian network analysis and dynamic modeling will be used to model the unexplored effects of epigenomic modulation of transcription on HER2/3 signaling.

National Institute of Health (NIH)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
United States
Zip Code
Werner, Henrica M J; Mills, Gordon B; Ram, Prahlad T (2014) Cancer Systems Biology: a peek into the future of patient care? Nat Rev Clin Oncol 11:167-76
Akbani, Rehan; Ng, Patrick Kwok Shing; Werner, Henrica M J et al. (2014) A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun 5:3887
Lee, Jiyoung; Lee, Jinho; Farquhar, Kevin S et al. (2014) Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. Proc Natl Acad Sci U S A 111:E364-73
Hines, William C; Su, Ying; Kuhn, Irene et al. (2014) Sorting out the FACS: a devil in the details. Cell Rep 6:779-81
Mertins, Philipp; Yang, Feng; Liu, Tao et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13:1690-704
Nishikawa, Taichiro; Bellance, Nad├Ęge; Damm, Aaron et al. (2014) A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol 60:1203-11
Iadevaia, Sergio; Nakhleh, Luay K; Azencott, Robert et al. (2014) Mapping network motif tunability and robustness in the design of synthetic signaling circuits. PLoS One 9:e91743
Hoadley, Katherine A; Yau, Christina; Wolf, Denise M et al. (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158:929-44
Cope, Leslie M; Fackler, Mary Jo; Lopez-Bujanda, Zoila et al. (2014) Do breast cancer cell lines provide a relevant model of the patient tumor methylome? PLoS One 9:e105545
Oates, Chris J; Dondelinger, Frank; Bayani, Nora et al. (2014) Causal network inference using biochemical kinetics. Bioinformatics 30:i468-74

Showing the most recent 10 out of 110 publications